RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 14, 2026, 16:55Clare Mansfield: Donor Conception Isn’t Just a Transaction
-
Aug 14, 2026, 16:49Lowell Ku: Cycle Tracking Isn’t Just About Knowing When Your Period Starts
-
Aug 14, 2026, 16:31Kahaani Mishra: An Enriching Experience at ACE Congress 2026
-
Aug 14, 2026, 16:23Evening of Networking, Conversation, and Connection in San Francisco – ASRM
-
Aug 14, 2026, 16:12Erand Llanaj: For Millions of Women, PCOS Was Never Just About the Ovaries…
-
Aug 13, 2026, 16:25Devyanshi Dixit: Building Healthier Futures Through Reproductive Health Education
-
Aug 13, 2026, 16:18Stephen Parker Ellington: An Encouraging Story for Fertility And Women’s Reproductive Choice
-
Aug 13, 2026, 16:09Kiani Davis: Fertility Patient Journey Series – Part 2
-
Aug 13, 2026, 16:02Lodovico Parmegiani: Live Births Following Universal Single-Step Warming Across Multiple Vitrification Systems